Cipla is planning to set up a Rs.384 crore manufacturing facility at Kurkumbh MIDC in Pune to meet growing demand of various products in the international market.

The new facility, with a capacity to produce 320 tonnes of API (active pharmaceutical ingredient) and 200 crore formulations per year, will produce antiretroviral, anti inflammatory, anti diabetic, anti bacterial, antipsychotic and anti hypertensive drugs.

The company has already submitted the project report to Maharashtra State Pollution Control Board and is awaiting for approval. Work on the project will soon commence once approval is granted.

The facility, which will come up near the existing plant of Cipla, is expected to create job opportunities for 400 people in Daund taluka of Pune district. Besides, it will provide direct and indirect employment to another 200 people.

Also see:

Cipla to set up plant in Bangalore (10-Sep-04)